Sterling Knight Ipamorelin 1 vial (10 mg) DERĪGUMA TERMIŅA BEIGAS

Ipamorelīns

Peptide selective agonist that targets the ghrelin/growth hormone secretagogue receptor and acts as a growth hormone secretagogue. This pentapeptide, with the amino acid sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2, originates from GHRP-1.

How It Works

Ipamorelīns binds to GHSR, activating it to trigger a biological response. Located in the ventromedial nucleus (VMN) of the hypothalamus, this receptor is essential for maintaining energy homeostasis, regulating caloric intake, and controlling body weight.

Ieguvumi

• Unlike other peptīdi, Ipamorelīns does not influence prolactin, a hormone involved in milk production, immune regulation, and pancreatic function.
• No negative effects on Follicle-Stimulating Hormone vai Luteinizing Hormone have been observed, both crucial for reproductive health in men and women.
• Preserves normal levels of Thyroid-Stimulating Hormone, vital for regulating metabolism and thyroid function, mitigating conditions such as hyperthyroidism and hypothyroidism.
• Does not stimulate the release of Adrenocorticotropic Hormone from the anterior pituitary gland, minimizing potential stress responses and cortisol elevation.
• Reportedly, cortisol levels remain stable, crucial for maintaining insulin balance, energy usage, and stress response.
• Maintains healthy blood pressure, contributing positively to overall physiological functions including memory, sexual performance, and cardiovascular health.

Dozēšana

Standard dosing of Ipamorelīns ranges from 200 to 300 mcg, administered 2 to 3 times daily, typically over a cycle of twelve weeks.

• Usage frequency: 2-3 times daily.
• Injection site: Subcutaneous fat around the abdominal area.
• Dosage per injection: 200-300 mcg.